INHIBITION OF GLUTAMATE-INDUCED CELL-DEATH BY SODIUM-NITROPRUSSIDE IS NOT MEDIATED BY NITRIC-OXIDE

被引:63
作者
KIEDROWSKI, L [1 ]
MANEV, H [1 ]
COSTA, E [1 ]
WROBLEWSKI, JT [1 ]
机构
[1] GEORGETOWN UNIV,SCH MED,FIDIA GEORGETOWN INST NEUROSCI,3900 RESERVOIR RD NW,WASHINGTON,DC 20007
关键词
NITRIC OXIDE; NMDA; KAINATE; CYCLIC GMP; S-NITROSO-N-ACETYLPENICILLAMINE; NEUROTOXICITY;
D O I
10.1016/0028-3908(91)90171-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pretreatment of primary cultures of cerebellar granule cells with sodium nitroprusside (SNP) protected these neurons from delayed death induced by glutamate and N-methyl-D-aspartate (NMDA). This neuroprotective effect was not mimicked by S-nitroso-N-acetylpenicillamine (SNAP) which like SNP stimulates guanylate cyclase via a nitric oxide (NO) related mechanism. In contrast, neuroprotection was achieved with potassium ferrocyanide, a compound structurally related to SNP, but devoid of NO. On the other hand, kainate-induced neurotoxicity was not protected but potentiated by SNP. This effect of SNP was not mimicked by SNAP, potassium ferrocyanide and potassium ferricyanide. We conclude that neuroprotective properties of SNP on glutamate- and NMDA-induced neurotoxicity are not due to the release of NO and activation of guanylate cyclase, but are determined by the ferrocyanide portion of the SNP molecule.
引用
收藏
页码:1241 / 1243
页数:3
相关论文
共 11 条
[1]   NITRIC-OXIDE MEDIATES GLUTAMATE-LINKED ENHANCEMENT OF CGMP LEVELS IN THE CEREBELLUM [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :9030-9033
[2]   UNUSUALLY STABLE THIONITRITE FROM N-ACETYL-D,L-PENICILLAMINE - X-RAY CRYSTAL AND MOLECULAR-STRUCTURE OF 2-(ACETYLAMINO)-2-CARBOXY-1,1-DIMETHYLETHYL THIONITRITE [J].
FIELD, L ;
DILTS, RV ;
RAVICHANDRAN, R ;
LENHERT, PG ;
CARNAHAN, GE .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1978, (06) :249-250
[3]   CYCLIC-GMP AND CELL-DEATH IN RAT CEREBELLAR SLICES [J].
GARTHWAITE, G ;
GARTHWAITE, J .
NEUROSCIENCE, 1988, 26 (01) :321-326
[4]  
HIBBS JB, 1987, J IMMUNOL, V138, P550
[5]  
IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739
[6]  
KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23
[7]  
KIEDROWSKI L, 1991, IN PRESS J NEUROCHEM
[8]  
MANEV H, 1989, MOL PHARMACOL, V36, P106
[9]  
MANEV H, 1991, TRANSMITTER AMINOACI